pembrolizumab,toripalimab,nivolumab,ipilimumab,Atezolizumab,durvalumab,Cisplatin,Gemcitabine,Pemetrexed
merck,Roche,BMS,Coherus,Junshi Biosciences,Astrazeneca
['nsclc', 'pembro', 'sclc']
 fantastic presentation by dr. on the significant role of neoadjuvant pembrolizumab in treating nsclc. impressive improvement in event-free survival (efs) across various subgroups demonstrated. #nsclc #immunotherapy #cancer #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.